4.7 Article

A paper-based microfluidic biosensor integrating zinc oxide nanowires for electrochemical glucose detection

Journal

MICROSYSTEMS & NANOENGINEERING
Volume 1, Issue -, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/micronano.2015.14

Keywords

electrochemical detection; enzymatic biosensor; glucose detection; paper-based microfluidics; zinc oxide nanowire

Funding

  1. Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 418553-12]
  2. Canada Foundation for Innovation [CFI-LOF 30316]
  3. McGill University [120536]
  4. Canadian Research Chairs Program [237293]
  5. McGill Chwang-Seto Faculty Scholarship Program [234304]
  6. NSERC-CREATE Training Program in Integrated Sensor Systems

Ask authors/readers for more resources

This paper reports an electrochemical microfluidic paper-based analytical device (E mu PAD) for glucose detection, featuring a highly sensitive working electrode (WE) decorated with zinc oxide nanowires (ZnO NWs). In addition to the common features of mu PADs, such as their low costs, high portability/disposability, and ease of operation, the reported E mu PAD has three further advantages. (i) It provides higher sensitivity and a lower limit of detection (LOD) than previously reported mu PADs because of the high surface-to-volume ratio and high enzyme-capturing efficiency of the ZnO NWs. (ii) It does not need any light-sensitive electron mediator (as is usually required in enzymatic glucose sensing), which leads to enhanced biosensing stability. (iii) The ZnO NWs are directly synthesized on the paper substrate via low-temperature hydrothermal growth, representing a simple, low-cost, consistent, and mass-producible process. To achieve superior analytical performance, the on-chip stored enzyme (glucose oxidase) dose and the assay incubation time are tuned. More importantly, the critical design parameters of the E mu PAD, including the WE area and the ZnO-NW growth level, are adjusted to yield tunable ranges for the assay sensitivity and LOD. The highest sensitivity that we have achieved is 8.24 mu A center dot mM(-1)center dot cm(-2), with a corresponding LOD of 59.5 mu M. By choosing the right combination of design parameters, we constructed E mu PADs that cover the range of clinically relevant glucose concentrations (0-15 mM) and fully calibrated these devices using spiked phosphate-buffered saline and human serum. We believe that the reported approach for integrating ZnO NWs on E mu PADs could be well utilized in many other designs of E mu PADs and provides a facile and inexpensive paradigm for further enhancing the device performance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available